Belmont Global Advisors’s Halozyme HALO Stock Holding History

Belmont Global Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$296K	–	69
2016 Q1	$284K	Buy	+30,000	New	+$282K	0.29%	48
2015 Q2	–	Sell	-232,300	Closed	-$3.32M	–	106
2015 Q1	$3.32M	Buy	232,300 +165,000	+245%	+$2.38M	3.37%	4
2014 Q4	$649K	Buy	67,300 +20,000	+42%	+$178K	0.64%	43
2014 Q3	$430K	Sell	47,300 -209,700	-82%	-$2M	0.34%	81
2014 Q2	$2.54M	Sell	257,000 -93,500	-27%	-$793K	1.83%	13
2014 Q1	$4.45M	Buy	350,500 +8,500	+2%	+$126K	3.74%	3
2013 Q4	$5.13M	Buy	+342,000	New	+$4.4M	4.14%	3

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Belmont Global Advisors's HALO Position: Q2 2016 in Review

Belmont Global Advisors sold out of Halozyme (HALO) in Q2 2016, closing a stake of 30,000 shares — an estimated $296K sold.

Belmont Global Advisors first reported a position in HALO in Q4 2013 and held it in 7 quarters. The position peaked at $5.13M in Q4 2013. 161 funds tracked by Wall St. Rank hold HALO as of Q2 2016.

Belmont Global Advisors reported no remaining Halozyme position as of Q2 2016 after selling out during the quarter.
Belmont Global Advisors sold 30,000 Halozyme shares in Q2 2016, an estimated $296K.
Belmont Global Advisors first reported a position in Halozyme in Q4 2013 and held it in 7 quarters.
Belmont Global Advisors's Halozyme position peaked at $5.13M in Q4 2013.
161 funds tracked by Wall St. Rank held Halozyme as of Q2 2016.

Based on Belmont Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.